Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""PALACE, J"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-12 z 12
    Tytuł:
    MOG encephalomyelitis: international recommendations on diagnosis and antibody testing.
    Autorzy:
    Jarius S; Molecular Neuroimmunology Group, Department of Neurology, University Hospital Heidelberg, Im Neuenheimer Feld 350, 69120, Heidelberg, Germany. .
    Paul F; Department of Neurology and Clinical and Experimental Multiple Sclerosis Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany.; NeuroCure Clinical Research Center and Clinical and Experimental Multiple Sclerosis Research Center, Berlin, Germany.
    Aktas O; Department of Neurology, University of Düsseldorf, Düsseldorf, Germany.
    Asgari N; Department of Neurology, University of Southern Denmark, Odense, Denmark.
    Dale RC; Children's Hospital at Westmead, University of Sydney, Sydney, Australia.
    de Seze J; Department of Neurology, Hôpital de Hautepierre, Strasbourg Cedex, France.
    Franciotta D; IRCCS, National Neurological Institute C. Mondino, Pavia, Italy.
    Fujihara K; Department of Multiple Sclerosis Therapeutics, Tohoku University Graduate School of Medicine, Sendai, Japan.
    Jacob A; The Walton Centre, Walton Centre NHS Foundation Trust, Liverpool, UK.
    Kim HJ; Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang, South Korea.
    Kleiter I; Department of Neurology, Ruhr University Bochum, Bochum, Germany.
    Kümpfel T; Institute of Clinical Neuroimmunology, Ludwig Maximilian University, Munich, Germany.
    Levy M; Department of Neurology, Johns Hopkins Hospital, Cleveland, USA.
    Palace J; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK.
    Ruprecht K; Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
    Saiz A; Service of Neurology, Hospital Clinic, and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.
    Trebst C; Department of Neurology, Hannover Medical School, Hanover, Germany.
    Weinshenker BG; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
    Wildemann B; Molecular Neuroimmunology Group, Department of Neurology, University Hospital Heidelberg, Im Neuenheimer Feld 350, 69120, Heidelberg, Germany. .
    Pokaż więcej
    Źródło:
    Journal of neuroinflammation [J Neuroinflammation] 2018 May 03; Vol. 15 (1), pp. 134. Date of Electronic Publication: 2018 May 03.
    Typ publikacji:
    Journal Article; Review
    MeSH Terms:
    Internationality*
    Autoantibodies/*blood
    Encephalomyelitis/*blood
    Encephalomyelitis/*diagnosis
    Immunoglobulin G/*blood
    Myelin-Oligodendrocyte Glycoprotein/*blood
    Animals ; Biomarkers/blood ; Humans ; Immunoenzyme Techniques/methods ; Immunoenzyme Techniques/trends
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease.
    Autorzy:
    Jurynczyk M; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Level 3, West Wing, Headley Way, Oxford, OX3 9DU, UK.; Department of Neurology, Medical University of Lodz, Lodz, Poland.
    Probert F; Department of Pharmacology, University of Oxford, Mansfield Road, Oxford, OX1 3QT, UK. .
    Yeo T; Department of Pharmacology, University of Oxford, Mansfield Road, Oxford, OX1 3QT, UK.; Department of Neurology, National Neuroscience Institute, 11 Jalan Tan Tock Seng, Singapore, 308433, Singapore.
    Tackley G; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Level 3, West Wing, Headley Way, Oxford, OX3 9DU, UK.
    Claridge TDW; Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Mansfield Road, Oxford, OX1 3TA, UK.
    Cavey A; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Level 3, West Wing, Headley Way, Oxford, OX3 9DU, UK.
    Woodhall MR; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Level 3, West Wing, Headley Way, Oxford, OX3 9DU, UK.
    Arora S; Mathematical Institute, University of Oxford, Woodstock Rd, Oxford, OX2 6GC, UK.
    Winkler T; Numares AG, Am Biopark 9, 93053, Regensburg, Germany.
    Schiffer E; Numares AG, Am Biopark 9, 93053, Regensburg, Germany.
    Vincent A; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Level 3, West Wing, Headley Way, Oxford, OX3 9DU, UK.
    DeLuca G; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Level 3, West Wing, Headley Way, Oxford, OX3 9DU, UK.
    Sibson NR; Cancer Research UK & Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, OX37DQ, Oxford, UK.
    Isabel Leite M; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Level 3, West Wing, Headley Way, Oxford, OX3 9DU, UK.
    Waters P; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Level 3, West Wing, Headley Way, Oxford, OX3 9DU, UK.
    Anthony DC; Department of Pharmacology, University of Oxford, Mansfield Road, Oxford, OX1 3QT, UK. .
    Palace J; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Level 3, West Wing, Headley Way, Oxford, OX3 9DU, UK. jacqueline.palace@ndcn.ox.ac.uk.
    Pokaż więcej
    Źródło:
    Acta neuropathologica communications [Acta Neuropathol Commun] 2017 Dec 06; Vol. 5 (1), pp. 95. Date of Electronic Publication: 2017 Dec 06.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Aquaporin 4/*immunology
    Autoantibodies/*blood
    Metabolomics/*methods
    Multiple Sclerosis, Relapsing-Remitting/*metabolism
    Myelin-Oligodendrocyte Glycoprotein/*immunology
    Neuromyelitis Optica/*metabolism
    Adolescent ; Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Lipoproteins/classification ; Magnetic Resonance Spectroscopy ; Male ; Middle Aged ; Multiple Sclerosis, Relapsing-Remitting/diagnosis ; Multiple Sclerosis, Relapsing-Remitting/immunology ; Neuromyelitis Optica/diagnosis ; Neuromyelitis Optica/immunology ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Induction of aquaporin 4-reactive antibodies in Lewis rats immunized with aquaporin 4 mimotopes.
    Autorzy:
    Tsymala I; Department Neuroimmunology, Medical University Vienna, Center for Brain Research, Spitalgasse 4, A-1090, Vienna, Austria.
    Nigritinou M; Department Neuroimmunology, Medical University Vienna, Center for Brain Research, Spitalgasse 4, A-1090, Vienna, Austria.
    Zeka B; Department Neuroimmunology, Medical University Vienna, Center for Brain Research, Spitalgasse 4, A-1090, Vienna, Austria.
    Schulz R; Department Neuroimmunology, Medical University Vienna, Center for Brain Research, Spitalgasse 4, A-1090, Vienna, Austria.
    Niederschick F; Department Neuroimmunology, Medical University Vienna, Center for Brain Research, Spitalgasse 4, A-1090, Vienna, Austria.
    Matković M; Department Neuroimmunology, Medical University Vienna, Center for Brain Research, Spitalgasse 4, A-1090, Vienna, Austria.
    Bauer IJ; Department Neuroimmunology, Medical University Vienna, Center for Brain Research, Spitalgasse 4, A-1090, Vienna, Austria.
    Szalay M; Department Pathobiology of the Nervous System, Medical University Vienna, Center for Brain Research, Spitalgasse 4, A-1090, Vienna, Austria.
    Schanda K; Clinical Department of Neurology, Medical University of Innsbruck, Innrain 66/2, A-6020, Innsbruck, Austria.
    Lerch M; Clinical Department of Neurology, Medical University of Innsbruck, Innrain 66/2, A-6020, Innsbruck, Austria.
    Misu T; Departments of Multiple Sclerosis Therapeutics and Neurology, Tohoku University Graduate School of Medicine, 1-1 Seiryomachi, Aobaku, Sendai, 980-8574, Japan.
    Fujihara K; Departments of Multiple Sclerosis Therapeutics and Neurology, Tohoku University Graduate School of Medicine, 1-1 Seiryomachi, Aobaku, Sendai, 980-8574, Japan.
    Bennett JL; Department of Neurology, Neuroscience Program, University of Colorado, Denver, CO, 80045, USA.
    Dahle C; Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Linköping, Sweden.
    Pache F; Department of Neurology and NeuroCure Clinical Research Center, Charité-Universitätsmedizin Berlin, Berlin, Germany.
    Rommer P; Department of Neurology, Medical University Vienna, Vienna, Austria.
    Leutmezer F; Department of Neurology, Medical University Vienna, Vienna, Austria.
    Illes Z; Department of Neurology, Odense University Hospital and University of Southern Denmark, Odense, Denmark.
    Leite MI; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK.
    Palace J; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK.
    Scholze P; Department Pathobiology of the Nervous System, Medical University Vienna, Center for Brain Research, Spitalgasse 4, A-1090, Vienna, Austria.
    Reindl M; Clinical Department of Neurology, Medical University of Innsbruck, Innrain 66/2, A-6020, Innsbruck, Austria.
    Lassmann H; Department Neuroimmunology, Medical University Vienna, Center for Brain Research, Spitalgasse 4, A-1090, Vienna, Austria.
    Bradl M; Department Neuroimmunology, Medical University Vienna, Center for Brain Research, Spitalgasse 4, A-1090, Vienna, Austria. .
    Pokaż więcej
    Źródło:
    Acta neuropathologica communications [Acta Neuropathol Commun] 2020 Apr 15; Vol. 8 (1), pp. 49. Date of Electronic Publication: 2020 Apr 15.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Disease Models, Animal*
    Aquaporin 4/*immunology
    Autoantibodies/*immunology
    Epitopes/*immunology
    Neuromyelitis Optica/*immunology
    Animals ; Autoantigens/immunology ; Humans ; Immunoglobulin G/immunology ; Rats ; Rats, Inbred Lew
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies.
    Autorzy:
    Yeo T; Department of Pharmacology, University of Oxford, Oxford, UK.; Department of Neurology, National Neuroscience Institute, Singapore, Singapore.
    Dos Passos GR; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.; Department of Neurology, Sao Lucas Hospital, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil.
    Muhammed L; Department of Neurology, Charing Cross Hospital, London, UK.
    Everett R; Department of Clinical Neurology, John Radcliffe Hospital, Oxford University Hospitals Trust, Oxford, UK.
    Reeve S; Department of Clinical Neurology, John Radcliffe Hospital, Oxford University Hospitals Trust, Oxford, UK.
    Messina S; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.; Department of Clinical Neurology, John Radcliffe Hospital, Oxford University Hospitals Trust, Oxford, UK.
    Probert F; Department of Pharmacology, University of Oxford, Oxford, UK.
    Leite MI; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.; Department of Clinical Neurology, John Radcliffe Hospital, Oxford University Hospitals Trust, Oxford, UK.
    Palace J; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.; Department of Clinical Neurology, John Radcliffe Hospital, Oxford University Hospitals Trust, Oxford, UK.
    Pokaż więcej
    Źródło:
    Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2020 Mar; Vol. 7 (3), pp. 375-383. Date of Electronic Publication: 2020 Mar 18.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Anxiety*/etiology
    Anxiety*/physiopathology
    Autoimmune Diseases of the Nervous System*/complications
    Autoimmune Diseases of the Nervous System*/immunology
    Autoimmune Diseases of the Nervous System*/physiopathology
    Central Nervous System Diseases*/complications
    Central Nervous System Diseases*/immunology
    Central Nervous System Diseases*/physiopathology
    Depression*/etiology
    Depression*/physiopathology
    Fatigue*/etiology
    Fatigue*/immunology
    Fatigue*/physiopathology
    Inflammation*/complications
    Inflammation*/immunology
    Inflammation*/physiopathology
    Pain*/etiology
    Pain*/physiopathology
    Severity of Illness Index*
    Aquaporin 4/*immunology
    Myelin-Oligodendrocyte Glycoprotein/*immunology
    Adult ; Aged ; Autoantibodies ; Cross-Sectional Studies ; Female ; Humans ; Male ; Middle Aged ; Time Factors
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Serological and experimental studies in different forms of myasthenia gravis.
    Autorzy:
    Vincent A; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
    Huda S; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
    Cao M; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
    Cetin H; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
    Koneczny I; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
    Rodriguez Cruz PM; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
    Jacobson L; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
    Viegas S; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
    Jacob S; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
    Woodhall M; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
    Nagaishi A; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
    Maniaol A; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
    Damato V; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
    Leite MI; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
    Cossins J; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
    Webster R; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
    Palace J; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
    Beeson D; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
    Pokaż więcej
    Źródło:
    Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 2018 Feb; Vol. 1413 (1), pp. 143-153. Date of Electronic Publication: 2018 Jan 29.
    Typ publikacji:
    Journal Article; Review
    MeSH Terms:
    Autoantibodies/*immunology
    Myasthenia Gravis/*immunology
    Receptor Protein-Tyrosine Kinases/*immunology
    Receptors, Cholinergic/*immunology
    Agrin/immunology ; Humans ; Immunoglobulin G/immunology ; Kv1.4 Potassium Channel/immunology ; LDL-Receptor Related Proteins/immunology ; Myasthenia Gravis/classification
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
    Autorzy:
    Paul F; Cecilie-Vogt-Clinic for Molecular Neurology, Charité, University Medicine Berlin, Berlin, Germany.
    Jarius S
    Aktas O
    Bluthner M
    Bauer O
    Appelhans H
    Franciotta D
    Bergamaschi R
    Littleton E
    Palace J
    Seelig HP
    Hohlfeld R
    Vincent A
    Zipp F
    Pokaż więcej
    Źródło:
    PLoS medicine [PLoS Med] 2007 Apr; Vol. 4 (4), pp. e133.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Radioimmunoprecipitation Assay*
    Aquaporin 4/*immunology
    Autoantibodies/*blood
    Neuromyelitis Optica/*diagnosis
    Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Diagnosis, Differential ; Female ; Humans ; Male ; Middle Aged ; Multiple Sclerosis/diagnosis ; Neuromyelitis Optica/immunology ; Recombinant Proteins ; Sensitivity and Specificity
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-12 z 12

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies